Overexpression of IL-21 is observed in tissues and sera of human patients with autoimmune diseases such as systematic lupus erythematosus (SLE), rheumatoid arthritis (RA), type 1 diabetes mellitus (DM), and primary Sjögren syndrome (SS) [28,29]. This evidence concerns the gene IL21 and systemic lupus erythematosus.